Loading clinical trials...
Loading clinical trials...
The study is designed as an open, non-randomized, phase IV cohort study in which the mRNA vaccine Comirnaty will be given in two doses. Analyses will be performed on blood and saliva, investigating hu...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Karolinska University Hospital
Collaborators
NCT07189936 · Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), and more
NCT04525716 · Covid19, Surgery
NCT03188796 · Critical Illness, Vitamin D Deficiency, and more
NCT04527315 · Covid19
NCT05013632 · Covid19
Karolinska University Hospital
Stockholm, Huddinge
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions